Skip to content

Using Patient Navigation to Promote Bowel Screening in AAA Attendees.

Testing the Efficacy, Feasibility, Acceptability and Cost-effectiveness of Patient Navigation to Promote Bowel Cancer Screening Participation Among Non-responders Attending Abdominal Aortic Aneurysm (AAA) Screening: A Multi-centre Pilot Study.

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07721740
Acronym
TET BETA
Enrollment
4190
Registered
2026-07-23
Start date
2026-08-03
Completion date
2027-07-31
Last updated
2026-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bowel Cancer Screening

Brief summary

The goal of this single-arm, multi-centre feasibility study is to assess the efficacy, feasibility and acceptability of implementing patient navigation across Abdominal Aortic Aneurysm (AAA) screening services in England to increase uptake of bowel cancer screening. The main questions it aims to answer are: * Do service users complete a bowel cancer screening within three months of receiving patient navigation? * Do service deliverers consider patient navigation as feasible to implement in practice? * Do service users consider patient navigation acceptable to receive during their AAA appointment? Participants will be asked to discuss bowel screening with AAA practitioners (patient navigation). Follow-up surveys and interviews will be conducted with those that delivered the intervention and with those that received it.

Detailed description

Bowel cancer is a leading cause of cancer-related mortality in England. Biennial Faecal Immunochemical Test (FIT) screening can reduce bowel cancer-related deaths by detecting cases before symptoms develop. However, uptake remains suboptimal, particularly among men. Evidence from a single-centre study in Scotland suggests that a brief intervention, akin to patient navigation, delivered to men attending routine abdominal aortic aneurysm (AAA) screening appointments, can facilitate participation. The overarching aim of this study is to evaluate the efficacy, feasibility, acceptability and cost-effectiveness of implementing patient navigation intervention across AAA screening services in England. This study will be a single-arm, multi-centre feasibility study that will be conducted across five AAA screening centres in England, i.e. Leicester, Birmingham and Black Country, London, West Yorkshire, and Somerset and North Devon. Over a three-month period (August-November 2026), AAA screening practitioners will deliver patient navigation to a sample of approximately 4190 men, aged 65+ years, who attend AAA screening and self-report as bowel screening non-responders. The primary outcome of the study is completion of a FIT kit within three months of the AAA appointment. Secondary outcomes include the feasibility, acceptability and cost-effectiveness of the intervention. The study comprises three Work Packages: Work Package 1 will be the single-arm, multi-centre feasibility study. The outcome will be the completion of a bowel cancer screening kit, providing preliminary evidence of efficacy. Work Package 2 will evaluate feasibility from the service provider perspective, using surveys (Workstream 2a) and interviews (Workstream 2b) with AAA service providers. Work Package 3 will assess acceptability from the service user perspective, using surveys (Workstream 3a) and interviews (Workstream 3b) with those who received the intervention during the study period. The findings will be used to inform an implementation toolkit as part of a national strategy to improve the uptake of bowel screening.

Interventions

OTHERPatient Navigation conversation

Brief 1.5-2 minute conversation to discuss barriers and solutions to why have not completed most recent bowel screening. Offer of third party request or information to contact screening service.

Sponsors

University of Surrey
Lead SponsorOTHER
Cancer Research UK
CollaboratorOTHER
NHS England
CollaboratorOTHER_GOV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
65 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Men aged 65 years and above * Attending an AAA screening appointment * Have not completed their most recent bowel screening * Agree to discuss bowel screening further

Exclusion criteria

* Men aged \<65years * Those who do not attend their AAA screening appointment * Have completed their most recent bowel screening * Do not agree to discuss bowel screening further * Those who received a positive AAA result in their appointment.

Design outcomes

Primary

MeasureTime frameDescription
Number of FIT test completedCompletion within 3 months of patient navigation interventionCompletion of FIT test

Secondary

MeasureTime frameDescription
Feasibility of delivering patient navigation (survey)0-5 months post patient navigation deliverySurvey with those who delivered patient navigation. Survey contains 7 items: 2 demographic questions, 2 items on a 3-point Likert scale (with option to provide further detail in open text), 2 open text responses, and one dichotomous item (Yes/No). The Likert scales are scored where 1 is low and 3 is high.
Feasibility of delivering patient navigation (Interviews)0-5 months post patient navigation deliverySemi-structured interviews with those who delivered patient navigation
Acceptability of receiving patient navigation (Survey)0-5 months post patient navigationSurvey with service users who received patient navigation. Survey contains 12 items: 4 demographic questions, 5 items on a 5-point Likert scale, and 3 open text responses. The Likert scales are scored where 1 is high and 5 is low.
Acceptability of receiving patient navigation (Interviews)0-5 months post patient navigationSemi-structured interviews with service users who received patient navigation

Countries

United Kingdom

Contacts

CONTACTElizabeth Bailey
assurance@surrey.ac.uk+441483 300800
PRINCIPAL_INVESTIGATORRobert Kerrison, PhD

University of Surrey

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 24, 2026